Jazz Pharmaceuticals plc

JAZZ

$200.62

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $12,350,237,696.00

EPSttm : -5.84

Jazz Pharmaceuticals plc

$200.62

2.72%

$5.31

JAZZ — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

11.19

Margin Of Safety %

-5

Put/Call OI Ratio

0.67

EPS Next Q Diff

0.26

EPS Last/This Y

29.9

EPS This/Next Y

1.02

Price

195.19

Target Price

225.44

Analyst Recom

1.47

Performance Q

21.21

Upside

-139.7%

Beta

0.24

Ticker: JAZZ

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	JAZZ	181.29	1.06	3.91	13894
2026-03-18	JAZZ	180.45	1.06	0.52	13985
2026-03-19	JAZZ	181.72	1.06	1.26	13984
2026-03-20	JAZZ	180.64	1.06	2.17	13845
2026-03-23	JAZZ	182.28	0.75	0.86	5967
2026-03-24	JAZZ	185	0.76	5.13	6013
2026-03-25	JAZZ	189.06	0.78	0.03	6093
2026-03-26	JAZZ	189	0.73	0.73	6335
2026-03-27	JAZZ	182.61	0.74	1.23	6450
2026-03-30	JAZZ	182.99	0.77	0.45	6692
2026-03-31	JAZZ	189.03	0.76	1.68	6798
2026-04-01	JAZZ	188.29	0.76	1.12	6801
2026-04-02	JAZZ	187	0.79	3.54	6844
2026-04-06	JAZZ	186.92	0.81	0.06	6905
2026-04-08	JAZZ	195.96	0.74	0.05	7238
2026-04-09	JAZZ	198.18	0.69	0.30	7612
2026-04-13	JAZZ	195.29	0.67	0.22	7925
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	JAZZ	181.29	172.0	1906.4	23.83
2026-03-18	JAZZ	180.45	172.0	1905.2	23.83
2026-03-19	JAZZ	181.83	172.0	1526.3	23.83
2026-03-20	JAZZ	180.62	172.0	1513.9	23.83
2026-03-23	JAZZ	182.22	172.0	1527.2	23.83
2026-03-24	JAZZ	184.92	174.1	1531.9	23.92
2026-03-25	JAZZ	188.98	174.1	1538.2	23.92
2026-03-26	JAZZ	189.21	174.1	1520.3	23.92
2026-03-27	JAZZ	182.61	174.1	1489.6	23.92
2026-03-30	JAZZ	183.06	174.1	1521.6	23.92
2026-03-31	JAZZ	188.94	174.4	1547.4	23.93
2026-04-01	JAZZ	188.38	174.4	1516.6	23.93
2026-04-02	JAZZ	186.87	174.4	1512.7	23.93
2026-04-06	JAZZ	186.87	174.4	1519.3	23.93
2026-04-07	JAZZ	190.98	174.4	1538.7	23.93
2026-04-09	JAZZ	198.14	174.4	1529.5	23.93
2026-04-10	JAZZ	194.17	179.5	1502.5	24.06
2026-04-13	JAZZ	195.19	179.5	1524.2	24.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	JAZZ	-5.89	0.95	10.29
2026-03-18	JAZZ	-5.89	0.95	10.29
2026-03-19	JAZZ	-5.89	0.95	10.29
2026-03-20	JAZZ	-5.89	0.95	10.29
2026-03-23	JAZZ	-5.89	0.99	10.29
2026-03-24	JAZZ	-5.89	0.99	10.29
2026-03-25	JAZZ	-5.89	0.99	10.57
2026-03-26	JAZZ	-5.89	0.99	10.57
2026-03-27	JAZZ	-5.89	0.99	10.57
2026-03-30	JAZZ	-5.89	0.99	10.57
2026-03-31	JAZZ	-5.89	0.99	10.57
2026-04-01	JAZZ	-5.89	0.99	10.57
2026-04-02	JAZZ	-5.89	0.99	10.57
2026-04-06	JAZZ	-5.90	0.99	10.57
2026-04-07	JAZZ	-5.90	0.99	10.57
2026-04-08	JAZZ	-5.90	0.99	10.57
2026-04-09	JAZZ	-5.90	0.99	10.57
2026-04-10	JAZZ	-5.90	0.99	10.57
2026-04-13	JAZZ	-5.90	1.06	11.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

5.76

Avg. EPS Est. Current Quarter

4.61

Avg. EPS Est. Next Quarter

6.02

Insider Transactions

-5.9

Institutional Transactions

1.06

Beta

0.24

Average Sales Estimate Current Quarter

977

Average Sales Estimate Next Quarter

1106

Fair Value

185.5

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.5

Max Drawdown 5-Year %

-47.5

Target Price

225.44

P/E

Forward P/E

7.77

PEG

0.16

P/S

2.82

P/B

2.78

P/Free Cash Flow

9.27

EPS

-5.97

Average EPS Est. Cur. Y

24.06

EPS Next Y. (Est.)

25.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.35

Relative Volume

1.02

Return on Equity vs Sector %

-35.6

Return on Equity vs Industry %

-19

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.23

EBIT Estimation

1524.2

◆ JAZZ Healthcare

$195.31

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

4/15

Valuation

9/20

TP/AR

4/10

Options

6/10

RSI

62.8

Range 1M

78.9%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

19/30

Estimates

5/20

Inst/Vol

8/15

Options

8/10

EPS Yr

187.3%

EPS NY

4.5%

52W%

95.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +35% upside

Quality

8/30

Valuation

15/30

Growth

13/25

Stability

4/10

LT Trend

1/5

Upside

+35%

Quality

MoS

-5%

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$200.62

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $12,350,237,696.00

EPSttm : -5.84

Jazz Pharmaceuticals plc

$200.62

2.72%

$5.31

JAZZ — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

11.19

Margin Of Safety %

-5

Put/Call OI Ratio

0.67

EPS Next Q Diff

0.26

EPS Last/This Y

29.9

EPS This/Next Y

1.02

Price

195.19

Target Price

225.44

Analyst Recom

1.47

Performance Q

21.21

Upside

-139.7%

Beta

0.24

Ticker: JAZZ

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	JAZZ	181.29	1.06	3.91	13894
2026-03-18	JAZZ	180.45	1.06	0.52	13985
2026-03-19	JAZZ	181.72	1.06	1.26	13984
2026-03-20	JAZZ	180.64	1.06	2.17	13845
2026-03-23	JAZZ	182.28	0.75	0.86	5967
2026-03-24	JAZZ	185	0.76	5.13	6013
2026-03-25	JAZZ	189.06	0.78	0.03	6093
2026-03-26	JAZZ	189	0.73	0.73	6335
2026-03-27	JAZZ	182.61	0.74	1.23	6450
2026-03-30	JAZZ	182.99	0.77	0.45	6692
2026-03-31	JAZZ	189.03	0.76	1.68	6798
2026-04-01	JAZZ	188.29	0.76	1.12	6801
2026-04-02	JAZZ	187	0.79	3.54	6844
2026-04-06	JAZZ	186.92	0.81	0.06	6905
2026-04-08	JAZZ	195.96	0.74	0.05	7238
2026-04-09	JAZZ	198.18	0.69	0.30	7612
2026-04-13	JAZZ	195.29	0.67	0.22	7925
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	JAZZ	181.29	172.0	1906.4	23.83
2026-03-18	JAZZ	180.45	172.0	1905.2	23.83
2026-03-19	JAZZ	181.83	172.0	1526.3	23.83
2026-03-20	JAZZ	180.62	172.0	1513.9	23.83
2026-03-23	JAZZ	182.22	172.0	1527.2	23.83
2026-03-24	JAZZ	184.92	174.1	1531.9	23.92
2026-03-25	JAZZ	188.98	174.1	1538.2	23.92
2026-03-26	JAZZ	189.21	174.1	1520.3	23.92
2026-03-27	JAZZ	182.61	174.1	1489.6	23.92
2026-03-30	JAZZ	183.06	174.1	1521.6	23.92
2026-03-31	JAZZ	188.94	174.4	1547.4	23.93
2026-04-01	JAZZ	188.38	174.4	1516.6	23.93
2026-04-02	JAZZ	186.87	174.4	1512.7	23.93
2026-04-06	JAZZ	186.87	174.4	1519.3	23.93
2026-04-07	JAZZ	190.98	174.4	1538.7	23.93
2026-04-09	JAZZ	198.14	174.4	1529.5	23.93
2026-04-10	JAZZ	194.17	179.5	1502.5	24.06
2026-04-13	JAZZ	195.19	179.5	1524.2	24.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	JAZZ	-5.89	0.95	10.29
2026-03-18	JAZZ	-5.89	0.95	10.29
2026-03-19	JAZZ	-5.89	0.95	10.29
2026-03-20	JAZZ	-5.89	0.95	10.29
2026-03-23	JAZZ	-5.89	0.99	10.29
2026-03-24	JAZZ	-5.89	0.99	10.29
2026-03-25	JAZZ	-5.89	0.99	10.57
2026-03-26	JAZZ	-5.89	0.99	10.57
2026-03-27	JAZZ	-5.89	0.99	10.57
2026-03-30	JAZZ	-5.89	0.99	10.57
2026-03-31	JAZZ	-5.89	0.99	10.57
2026-04-01	JAZZ	-5.89	0.99	10.57
2026-04-02	JAZZ	-5.89	0.99	10.57
2026-04-06	JAZZ	-5.90	0.99	10.57
2026-04-07	JAZZ	-5.90	0.99	10.57
2026-04-08	JAZZ	-5.90	0.99	10.57
2026-04-09	JAZZ	-5.90	0.99	10.57
2026-04-10	JAZZ	-5.90	0.99	10.57
2026-04-13	JAZZ	-5.90	1.06	11.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

5.76

Avg. EPS Est. Current Quarter

4.61

Avg. EPS Est. Next Quarter

6.02

Insider Transactions

-5.9

Institutional Transactions

1.06

Beta

0.24

Average Sales Estimate Current Quarter

977

Average Sales Estimate Next Quarter

1106

Fair Value

185.5

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.5

Max Drawdown 5-Year %

-47.5

Target Price

225.44

P/E

Forward P/E

7.77

PEG

0.16

P/S

2.82

P/B

2.78

P/Free Cash Flow

9.27

EPS

-5.97

Average EPS Est. Cur. Y

24.06

EPS Next Y. (Est.)

25.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.35

Relative Volume

1.02

Return on Equity vs Sector %

-35.6

Return on Equity vs Industry %

-19

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.23

EBIT Estimation

1524.2

◆ JAZZ Healthcare

$195.31

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

4/15

Valuation

9/20

TP/AR

4/10

Options

6/10

RSI

62.8

Range 1M

78.9%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

19/30

Estimates

5/20

Inst/Vol

8/15

Options

8/10

EPS Yr

187.3%

EPS NY

4.5%

52W%

95.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +35% upside

Quality

8/30

Valuation

15/30

Growth

13/25

Stability

4/10

LT Trend

1/5

Upside

+35%

Quality

MoS

-5%

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y